(Q83438677)
Statements
Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment (English)
M Nowicki
I Rychlik
H Haller
M L Warren
L Suchower
I Gause-Nilsson
D1680C00007 Investigators